BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35902630)

  • 1. Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.
    Yang Y; Seok MJ; Kim YE; Choi Y; Song JJ; Sulistio YA; Kim SH; Chang MY; Oh SJ; Nam MH; Kim YK; Kim TG; Im HI; Koh SH; Lee SH
    Mol Psychiatry; 2023 Dec; 28(12):5359-5374. PubMed ID: 35902630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.
    Oh SM; Chang MY; Song JJ; Rhee YH; Joe EH; Lee HS; Yi SH; Lee SH
    EMBO Mol Med; 2015 May; 7(5):510-25. PubMed ID: 25759364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.
    Moon M; Jung ES; Jeon SG; Cha MY; Jang Y; Kim W; Lopes C; Mook-Jung I; Kim KS
    Aging Cell; 2019 Feb; 18(1):e12866. PubMed ID: 30515963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease.
    Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS
    J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.
    Yang Y; Seok MJ; Kim YE; Choi Y; Song JJ; Sulistio YA; Kim SH; Chang MY; Oh SJ; Nam MH; Kim YK; Kim TG; Im HI; Koh SH; Lee SH
    Mol Psychiatry; 2023 Dec; 28(12):5375-5377. PubMed ID: 37429989
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction to: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.
    Yang Y; Seok MJ; Kim YE; Choi Y; Song JJ; Sulistio YA; Kim SH; Chang MY; Oh SJ; Nam MH; Kim YK; Kim TG; Im HI; Koh SH; Lee SH
    Mol Psychiatry; 2023 Dec; 28(12):5378-5379. PubMed ID: 37020051
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
    Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM
    Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.
    Fukuchi K; Tahara K; Kim HD; Maxwell JA; Lewis TL; Accavitti-Loper MA; Kim H; Ponnazhagan S; Lalonde R
    Neurobiol Dis; 2006 Sep; 23(3):502-11. PubMed ID: 16766200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.
    Lee HS; Bae EJ; Yi SH; Shim JW; Jo AY; Kang JS; Yoon EH; Rhee YH; Park CH; Koh HC; Kim HJ; Choi HS; Han JW; Lee YS; Kim J; Li JY; Brundin P; Lee SH
    Stem Cells; 2010 Mar; 28(3):501-12. PubMed ID: 20049900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation.
    Yi SH; He XB; Rhee YH; Park CH; Takizawa T; Nakashima K; Lee SH
    Development; 2014 Feb; 141(4):761-72. PubMed ID: 24496614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer's disease-like pathology and cognitive deficits in mice.
    Zeng CY; Yang TT; Zhou HJ; Zhao Y; Kuang X; Duan W; Du JR
    Neurobiol Aging; 2019 Jun; 78():18-28. PubMed ID: 30851437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.
    Caccamo A; Maldonado MA; Bokov AF; Majumder S; Oddo S
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22687-92. PubMed ID: 21149712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease.
    Murphy SR; Chang CC; Dogbevia G; Bryleva EY; Bowen Z; Hasan MT; Chang TY
    Mol Ther; 2013 Aug; 21(8):1497-506. PubMed ID: 23774792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice.
    Ryan DA; Mastrangelo MA; Narrow WC; Sullivan MA; Federoff HJ; Bowers WJ
    Mol Ther; 2010 Aug; 18(8):1471-81. PubMed ID: 20551911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer's disease.
    Elmer BM; Swanson KA; Bangari DS; Piepenhagen PA; Roberts E; Taksir T; Guo L; Obinu MC; Barneoud P; Ryan S; Zhang B; Pradier L; Yang ZY; Nabel GJ
    PLoS One; 2019; 14(12):e0226245. PubMed ID: 31887144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis.
    Guo K; Huang W; Chen K; Huang P; Peng W; Shi R; He T; Zhang M; Wang H; Hu J; Wang X; Shentu Y; Xu H; Lin L
    Aging Cell; 2023 Sep; 22(9):e13937. PubMed ID: 37503695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensatory Expression of Nur77 and Nurr1 Regulates NF-
    Popichak KA; Hammond SL; Moreno JA; Afzali MF; Backos DS; Slayden RD; Safe S; Tjalkens RB
    Mol Pharmacol; 2018 Oct; 94(4):1174-1186. PubMed ID: 30111648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.